BSE filing, NSE: INDOMIM. Summary written from the filing by ALFA Finder's alert engine.
Indo-MIM Ltd: key numbers
- Share price
- ₹1,276.40
- Market cap
- ₹63,116 Cr
- Revenue (annual)
- ₹4,193 Cr
- Net profit (annual)
- ₹533.5 Cr
- Promoter holding
- 77.65%
- FII holding
- 2.46%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indo-MIM Ltd
All →Indo-MIM Q2 FY27 Results: Net Profit ₹215.2 Cr, Up 100.0% YoY
Indo-MIM Ltd reported revenue from operations of ₹1,272 Cr (+14.3% YoY) and net profit of ₹215.2 Cr (+100.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹215.2 Cr · +100.0% YoY
Indo-MIM Board Meeting Date
INDO-MIM Ltd informed exchanges of a board meeting on November 13, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. The trading window stays closed until 48 hours after results.
Indo-MIM Annual General Meeting
INDO-MIM seeks postal ballot approval to re-appoint three independent directors for five years from March 2027. E-voting runs 5 November to 4 December 2026.
Indo-MIM Other Announcement
INDO-MIM Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31(1)(b).
Indo-MIM Merger & Restructuring Worth ₹45 Cr
INDO-MIM's board approved incorporation of a wholly-owned manufacturing subsidiary in Vietnam. The company will invest ₹45 Crore over five years for electronics assembly and export.
- Value
- ₹45.00 Cr
- Execution
- 5 years
Indo-MIM Management Change
INDO-MIM Limited announced the re-appointment of Mrs. Rajni Anil Mishra, Mrs. Meera Shankar, and Mrs. Sujitha Karnad as Non-Executive Independent Directors for a 60-month term.
Other other announcement announcements
All →Religare Enterprises Other Announcement
Religare Enterprises filed CARE Ratings' monitoring agency report for the quarter ended September 30, 2026, on its Rs 1,500 crore preferential warrant issue. The report states proceeds were used per the offer document with no deviation.
Optivalue Tek Consulting Other Announcement
Optivalue Tek filed Acuité's half-yearly monitoring report on IPO proceeds for H1 FY2026-27. No deviation from the offer objects was observed.
5Paisa Capital Other Announcement
5paisa Capital Ltd filed its quarterly shareholding pattern under Regulation 31(1)(c). It reports routine holding figures with no new transaction or corporate event.
Chennai Meenakshi Multispeciality Hospital Other Announcement
Chennai Meenakshi Multispeciality Hospital issued a duplicate share certificate for 100 shares to Inder Chand Kothari L under folio 00008717. The intimation is routine share-certificate paperwork with no transaction or money involved.
Axel Polymers Other Announcement
Axel Polymers reports no deviation in utilisation of its Rs 11.18 Crore preferential issue proceeds for the quarter ended 30 September 2026. This is a routine Regulation 32 statement of deviation with a clean auditor certificate.
360 One Wam Other Announcement
360 ONE WAM disclosed PIT sales by five insiders on 12 November 2026, totalling about Rs 3.55 Crore. The sellers are designated persons, KMP and an employee's relative, with no promoter involved.
- Value
- ₹3.55 Cr